Review



huvecs  (Angio-Proteomie)


Bioz Verified Symbol Angio-Proteomie is a verified supplier
Bioz Manufacturer Symbol Angio-Proteomie manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    Angio-Proteomie huvecs
    (A) Quantitative analysis of BrdU incorporation assay <t>measuring</t> <t>endothelial</t> cell proliferation. (B) Quantitative analysis of HUVEC migration and (C) representative images of HUVEC migration. Scale bar=100 µm. (D) Plot of HUVEC migration for 24 hours. (E) Representative images of <t>GFP-HUVECs</t> which were treated with 1 µg/mL EVs for 9 hours on GelTrex. Scale bar=500 µm. (F) Quantitative analysis of number of branches and (G) total tube length. Error bars in the graphs represent mean ± SD of EVs obtained from three or four independent donors. ****p < 0.0001, ***p <0.001, **p < 0.01, *p <0.05 (one-way ANOVA and Tukey multiple comparison).
    Huvecs, supplied by Angio-Proteomie, used in various techniques. Bioz Stars score: 95/100, based on 101 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gfp+huvec/GFP+Expressing+Human+Umbilical+Vein+Endothelial+Cells/bio_rxiv__64898__2026__01__16__699890-281-13-14
    Average 95 stars, based on 101 article reviews
    huvecs - by Bioz Stars, 2026-10
    95/100 stars

    Images

    1) Product Images from "Metabolic Reprogramming of Human Macrophages Drives the Formation of Hybrid M1/M2 Pro-Regenerative Extracellular Vesicles"

    Article Title: Metabolic Reprogramming of Human Macrophages Drives the Formation of Hybrid M1/M2 Pro-Regenerative Extracellular Vesicles

    Journal: bioRxiv

    doi: 10.64898/2026.01.16.699890

    (A) Quantitative analysis of BrdU incorporation assay measuring endothelial cell proliferation. (B) Quantitative analysis of HUVEC migration and (C) representative images of HUVEC migration. Scale bar=100 µm. (D) Plot of HUVEC migration for 24 hours. (E) Representative images of GFP-HUVECs which were treated with 1 µg/mL EVs for 9 hours on GelTrex. Scale bar=500 µm. (F) Quantitative analysis of number of branches and (G) total tube length. Error bars in the graphs represent mean ± SD of EVs obtained from three or four independent donors. ****p < 0.0001, ***p <0.001, **p < 0.01, *p <0.05 (one-way ANOVA and Tukey multiple comparison).
    Figure Legend Snippet: (A) Quantitative analysis of BrdU incorporation assay measuring endothelial cell proliferation. (B) Quantitative analysis of HUVEC migration and (C) representative images of HUVEC migration. Scale bar=100 µm. (D) Plot of HUVEC migration for 24 hours. (E) Representative images of GFP-HUVECs which were treated with 1 µg/mL EVs for 9 hours on GelTrex. Scale bar=500 µm. (F) Quantitative analysis of number of branches and (G) total tube length. Error bars in the graphs represent mean ± SD of EVs obtained from three or four independent donors. ****p < 0.0001, ***p <0.001, **p < 0.01, *p <0.05 (one-way ANOVA and Tukey multiple comparison).

    Techniques Used: BrdU Incorporation Assay, Migration, Comparison

    (A) Quantitative analysis of BrdU incorporation assay measuring endothelial cell proliferation. (B) Quantitative analysis of HUVEC migration and (C) representative images of HUVEC migration. Scale bar= 100 µm. (D) Representative images of GFP-HUVECs which were treated with 1 µg/mL EVs for 9 hours on GelTrex. Scale bar=500 µm. ( E ) Quantitative analysis of number of branches and ( F ) total tube length. (G) Quantitative analysis of BrdU incorporation assay measuring MSC proliferation. (H) Quantitative analysis of MSC migration. (I) Alkaline phosphatase activity at day 7. (J) Alizarin Red staining at day 14 for mineralized matrix deposition (Scale bar=100 µm) and (K) quantification of calcium content. Error bars in the graphs represent mean ± SD of EVs obtained from three or four independent donors. ****p < 0.0001, ***p < 0.001, **p < 0.01, *p < 0.05 (one-way ANOVA and Tukey multiple comparison). Error bars in the graphs represent mean ± SD of EVs obtained from three or four independent donors.
    Figure Legend Snippet: (A) Quantitative analysis of BrdU incorporation assay measuring endothelial cell proliferation. (B) Quantitative analysis of HUVEC migration and (C) representative images of HUVEC migration. Scale bar= 100 µm. (D) Representative images of GFP-HUVECs which were treated with 1 µg/mL EVs for 9 hours on GelTrex. Scale bar=500 µm. ( E ) Quantitative analysis of number of branches and ( F ) total tube length. (G) Quantitative analysis of BrdU incorporation assay measuring MSC proliferation. (H) Quantitative analysis of MSC migration. (I) Alkaline phosphatase activity at day 7. (J) Alizarin Red staining at day 14 for mineralized matrix deposition (Scale bar=100 µm) and (K) quantification of calcium content. Error bars in the graphs represent mean ± SD of EVs obtained from three or four independent donors. ****p < 0.0001, ***p < 0.001, **p < 0.01, *p < 0.05 (one-way ANOVA and Tukey multiple comparison). Error bars in the graphs represent mean ± SD of EVs obtained from three or four independent donors.

    Techniques Used: BrdU Incorporation Assay, Migration, Activity Assay, Staining, Comparison

    Related Articles

    other:

    Article Title: Spheroid Cell Aggregation Enhanced by Enzyme‐Free Ultrasound‐Detached Cells
    Article Snippet: The detachment is the highest while not hurting the cells at 125 V with 84% detachment and 100% living ratio for GFP‐HUVEC (GFP‐HUVEC, cAP‐0001GFP, ANGIO‐PROTEOMIE, Boston, USA).

    Cell Culture:

    Article Title: Engineering Tissue-Specific, Multiscale Microvasculature with a Capillary Network for Prevascularized Tissue.
    Article Snippet: DOI: 10.1002/smtd.202100632 microtechnologies with conventional capillary induction methods have been developed.. [7–21] Endothelialized channels with diameters of several hundred micrometers were fabricated using microtechnologies such as 3D bioprinting,[7–10] lithography,[11–16] and sacrificial templates;[17–21] capillary networks connected to these channels were induced using angiogenic factors such as the vascular endothelial growth factor (VEGF) and fibroblast growth factors.. The produced multiscale vasculature exhibited improved mass transport capacity and could significantly improve the functions of engineered tissues.

    Article Title: A novel strategy to engineer pre-vascularized 3-dimensional skin substitutes to achieve efficient, functional engraftment
    Article Snippet: Neonatal normal human dermal fibroblasts (NHDF, CC-2509; Lonza, Basel, Switzerland) were cultured in Dulbecco’s modified Eagle’s medium (DMEM, Nacalai Tesque, Kyoto, Japan) supplemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin, 100 μg/mL streptomycin, and 0.25 μg/mL amphotericin B at 37 °C in 5% CO 2 . .. Human umbilical vein endothelial cells (HUVEC; Lonza) and GFP-HUVEC (Angio-Proteomie, Boston, MA, USA) were cultured in endothelial cell medium (EGM-2MV, Lonza). .. After reaching 80–90% confluency, the NHDF and HUVEC were subcultured using 0.25% trypsin/EDTA solution (Lonza) and used at passage 5 to construct the 3D skin models.

    Isolation:

    Article Title: Engineering Tissue-Specific, Multiscale Microvasculature with a Capillary Network for Prevascularized Tissue.
    Article Snippet: DOI: 10.1002/smtd.202100632 microtechnologies with conventional capillary induction methods have been developed.. [7–21] Endothelialized channels with diameters of several hundred micrometers were fabricated using microtechnologies such as 3D bioprinting,[7–10] lithography,[11–16] and sacrificial templates;[17–21] capillary networks connected to these channels were induced using angiogenic factors such as the vascular endothelial growth factor (VEGF) and fibroblast growth factors.. The produced multiscale vasculature exhibited improved mass transport capacity and could significantly improve the functions of engineered tissues.

    Centrifugation:

    Article Title: Injectable Prevascularized Mature Adipose Tissues (iPAT) to Achieve Long-Term Survival in Soft Tissue Regeneration.
    Article Snippet: Soft tissue regeneration remains a challenge in reconstructive surgery.. So far, both autologous fat implantations and artificial implants methods used in clinical applications lead to various disadvantages and limited lifespan.. To overcome these limitations and improve the graft volume maintenance, reproducing a mature adipose tissue already including vasculature structure before implantation can be the solution.

    Concentration Assay:

    Article Title: Injectable Prevascularized Mature Adipose Tissues (iPAT) to Achieve Long-Term Survival in Soft Tissue Regeneration.
    Article Snippet: Soft tissue regeneration remains a challenge in reconstructive surgery.. So far, both autologous fat implantations and artificial implants methods used in clinical applications lead to various disadvantages and limited lifespan.. To overcome these limitations and improve the graft volume maintenance, reproducing a mature adipose tissue already including vasculature structure before implantation can be the solution.

    Imaging:

    Article Title: Injectable Prevascularized Mature Adipose Tissues (iPAT) to Achieve Long-Term Survival in Soft Tissue Regeneration.
    Article Snippet: Soft tissue regeneration remains a challenge in reconstructive surgery.. So far, both autologous fat implantations and artificial implants methods used in clinical applications lead to various disadvantages and limited lifespan.. To overcome these limitations and improve the graft volume maintenance, reproducing a mature adipose tissue already including vasculature structure before implantation can be the solution.

    Injection:

    Article Title: Injectable Prevascularized Mature Adipose Tissues (iPAT) to Achieve Long-Term Survival in Soft Tissue Regeneration.
    Article Snippet: Soft tissue regeneration remains a challenge in reconstructive surgery.. So far, both autologous fat implantations and artificial implants methods used in clinical applications lead to various disadvantages and limited lifespan.. To overcome these limitations and improve the graft volume maintenance, reproducing a mature adipose tissue already including vasculature structure before implantation can be the solution.



    Similar Products

    98
    PromoCell human umbilical vein endothelial cells huvec gfp
    Acid-stimulated S1P, released by tumor cells, promotes tubulogenesis. (A,B) Quantifications and representative images <t>of</t> <t>HUVEC-GFP</t> cells treated with the CM of OS spheroids cultured in neutral or acidic conditions for 24 h (scale bar: 800 μm). The corresponding control (−) consisted of medium maintained at the same pH as that used for the spheroids. Mann–Whitney test (*p < 0.05 and **p < 0.01 versus neutral control; §§p < 0.01 vs. CM acid control; ###p < 0.005 vs. CM neutral control; n = 12). (C) S1P levels in CM of OS spheroids cultured for 96 h, at nuetral and acidic conditions, with or w/o FTY720 were determined by ELISA. Mann–Whitney test (*p < 0.05 vs. neutral control, #p < 0.05 vs. acid control). (D,E) Quantifications and representative images of HUVEC-GFP cells treated with the CM of OS spheroids, treated with FTY720, as indicated (scale bar: 800 μm). Mann–Whitney test (*p < 0.05 and ***p < 0.005 vs. neutral untreated control; #p < 0.05 vs. CM acid untreated control; n = 12). For all the experiments data are presented as mean ± SEM.
    Human Umbilical Vein Endothelial Cells Huvec Gfp, supplied by PromoCell, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gfp+huvec/Human+Umbilical+Vein+Endothelial+Cells+(HUVEC)+single+donor/pmc13233457-35-0-9
    Average 98 stars, based on 1 article reviews
    human umbilical vein endothelial cells huvec gfp - by Bioz Stars, 2026-10
    98/100 stars
      Buy from Supplier

    98
    AvesLabs huvecs
    Acid-stimulated S1P, released by tumor cells, promotes tubulogenesis. (A,B) Quantifications and representative images <t>of</t> <t>HUVEC-GFP</t> cells treated with the CM of OS spheroids cultured in neutral or acidic conditions for 24 h (scale bar: 800 μm). The corresponding control (−) consisted of medium maintained at the same pH as that used for the spheroids. Mann–Whitney test (*p < 0.05 and **p < 0.01 versus neutral control; §§p < 0.01 vs. CM acid control; ###p < 0.005 vs. CM neutral control; n = 12). (C) S1P levels in CM of OS spheroids cultured for 96 h, at nuetral and acidic conditions, with or w/o FTY720 were determined by ELISA. Mann–Whitney test (*p < 0.05 vs. neutral control, #p < 0.05 vs. acid control). (D,E) Quantifications and representative images of HUVEC-GFP cells treated with the CM of OS spheroids, treated with FTY720, as indicated (scale bar: 800 μm). Mann–Whitney test (*p < 0.05 and ***p < 0.005 vs. neutral untreated control; #p < 0.05 vs. CM acid untreated control; n = 12). For all the experiments data are presented as mean ± SEM.
    Huvecs, supplied by AvesLabs, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gfp+huvec/Anti-Green+Fluorescent+Protein+(GFP)+Antibody/pm41949899-407-5-9
    Average 98 stars, based on 1 article reviews
    huvecs - by Bioz Stars, 2026-10
    98/100 stars
      Buy from Supplier

    95
    Angio-Proteomie huvecs
    (A) Quantitative analysis of BrdU incorporation assay <t>measuring</t> <t>endothelial</t> cell proliferation. (B) Quantitative analysis of HUVEC migration and (C) representative images of HUVEC migration. Scale bar=100 µm. (D) Plot of HUVEC migration for 24 hours. (E) Representative images of <t>GFP-HUVECs</t> which were treated with 1 µg/mL EVs for 9 hours on GelTrex. Scale bar=500 µm. (F) Quantitative analysis of number of branches and (G) total tube length. Error bars in the graphs represent mean ± SD of EVs obtained from three or four independent donors. ****p < 0.0001, ***p <0.001, **p < 0.01, *p <0.05 (one-way ANOVA and Tukey multiple comparison).
    Huvecs, supplied by Angio-Proteomie, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gfp+huvec/GFP+Expressing+Human+Umbilical+Vein+Endothelial+Cells/bio_rxiv__64898__2026__01__16__699890-281-13-14
    Average 95 stars, based on 1 article reviews
    huvecs - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    95
    Angio-Proteomie rfp
    (A) Quantitative analysis of BrdU incorporation assay <t>measuring</t> <t>endothelial</t> cell proliferation. (B) Quantitative analysis of HUVEC migration and (C) representative images of HUVEC migration. Scale bar=100 µm. (D) Plot of HUVEC migration for 24 hours. (E) Representative images of <t>GFP-HUVECs</t> which were treated with 1 µg/mL EVs for 9 hours on GelTrex. Scale bar=500 µm. (F) Quantitative analysis of number of branches and (G) total tube length. Error bars in the graphs represent mean ± SD of EVs obtained from three or four independent donors. ****p < 0.0001, ***p <0.001, **p < 0.01, *p <0.05 (one-way ANOVA and Tukey multiple comparison).
    Rfp, supplied by Angio-Proteomie, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gfp+huvec/GFP+Expressing+Human+Umbilical+Vein+Endothelial+Cells/pm41493112-423-2-3
    Average 95 stars, based on 1 article reviews
    rfp - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    96
    Angio-Proteomie embodiments human umbilical vein endothelial cells huvec green florescent paint gfp
    (A) Quantitative analysis of BrdU incorporation assay <t>measuring</t> <t>endothelial</t> cell proliferation. (B) Quantitative analysis of HUVEC migration and (C) representative images of HUVEC migration. Scale bar=100 µm. (D) Plot of HUVEC migration for 24 hours. (E) Representative images of <t>GFP-HUVECs</t> which were treated with 1 µg/mL EVs for 9 hours on GelTrex. Scale bar=500 µm. (F) Quantitative analysis of number of branches and (G) total tube length. Error bars in the graphs represent mean ± SD of EVs obtained from three or four independent donors. ****p < 0.0001, ***p <0.001, **p < 0.01, *p <0.05 (one-way ANOVA and Tukey multiple comparison).
    Embodiments Human Umbilical Vein Endothelial Cells Huvec Green Florescent Paint Gfp, supplied by Angio-Proteomie, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gfp+huvec/Human+Umbilical+Vein+Endothelial+Cells/us12496775-932-5-15
    Average 96 stars, based on 1 article reviews
    embodiments human umbilical vein endothelial cells huvec green florescent paint gfp - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    96
    Angio-Proteomie umbilical vein endothelial cells gfp huvecs
    (A) Quantitative analysis of BrdU incorporation assay <t>measuring</t> <t>endothelial</t> cell proliferation. (B) Quantitative analysis of HUVEC migration and (C) representative images of HUVEC migration. Scale bar=100 µm. (D) Plot of HUVEC migration for 24 hours. (E) Representative images of <t>GFP-HUVECs</t> which were treated with 1 µg/mL EVs for 9 hours on GelTrex. Scale bar=500 µm. (F) Quantitative analysis of number of branches and (G) total tube length. Error bars in the graphs represent mean ± SD of EVs obtained from three or four independent donors. ****p < 0.0001, ***p <0.001, **p < 0.01, *p <0.05 (one-way ANOVA and Tukey multiple comparison).
    Umbilical Vein Endothelial Cells Gfp Huvecs, supplied by Angio-Proteomie, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gfp+huvec/Human+Umbilical+Vein+Endothelial+Cells/us12433937-669-7-12
    Average 96 stars, based on 1 article reviews
    umbilical vein endothelial cells gfp huvecs - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    95
    Angio-Proteomie primary huvec
    (A) Quantitative analysis of BrdU incorporation assay <t>measuring</t> <t>endothelial</t> cell proliferation. (B) Quantitative analysis of HUVEC migration and (C) representative images of HUVEC migration. Scale bar=100 µm. (D) Plot of HUVEC migration for 24 hours. (E) Representative images of <t>GFP-HUVECs</t> which were treated with 1 µg/mL EVs for 9 hours on GelTrex. Scale bar=500 µm. (F) Quantitative analysis of number of branches and (G) total tube length. Error bars in the graphs represent mean ± SD of EVs obtained from three or four independent donors. ****p < 0.0001, ***p <0.001, **p < 0.01, *p <0.05 (one-way ANOVA and Tukey multiple comparison).
    Primary Huvec, supplied by Angio-Proteomie, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gfp+huvec/GFP+Expressing+Human+Umbilical+Vein+Endothelial+Cells/pmc12491524-48-0-3
    Average 95 stars, based on 1 article reviews
    primary huvec - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    95
    Angio-Proteomie gfp huvec
    (A) Quantitative analysis of BrdU incorporation assay <t>measuring</t> <t>endothelial</t> cell proliferation. (B) Quantitative analysis of HUVEC migration and (C) representative images of HUVEC migration. Scale bar=100 µm. (D) Plot of HUVEC migration for 24 hours. (E) Representative images of <t>GFP-HUVECs</t> which were treated with 1 µg/mL EVs for 9 hours on GelTrex. Scale bar=500 µm. (F) Quantitative analysis of number of branches and (G) total tube length. Error bars in the graphs represent mean ± SD of EVs obtained from three or four independent donors. ****p < 0.0001, ***p <0.001, **p < 0.01, *p <0.05 (one-way ANOVA and Tukey multiple comparison).
    Gfp Huvec, supplied by Angio-Proteomie, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gfp+huvec/GFP+Expressing+Human+Umbilical+Vein+Endothelial+Cells/pmc12365725-82-21-24
    Average 95 stars, based on 1 article reviews
    gfp huvec - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    95
    Angio-Proteomie human umbilical vein endothelial cells huvecs
    A and B , Bioluminescence of HEK-293T VEGFR reporter cells treated with supernatant containing either anti-VEGF or anti-CD19 and recombinant VEGF (rVEGF) (Data from technical triplicates, points represent the mean, error bars represent SEM, p-value by two-way ANOVA) ( A ) or supernatant from confluent VEGF-producing 786O tumor cells (data from technical triplicates, lines represent the median, p-value by one-way ANOVA) ( B ). C, Schematic of in vitro angiogenesis assay to visualize blood vessel formation upon blocking VEGF. GFP + human umbilical vein <t>endothelial</t> cells <t>(HUVECs)</t> were cocultured with normal human dermal fibroblasts (NHDFs), suramin, rVEGF, and culture supernatant from CAR αCD19 or CAR αVEGF constructs and primitive blood vessel formation was imaged over time on the incucyte. D, Representative images of GFP + HUVECs with vessels labeled by the automated incucyte angiogenesis software package. E, HUVEC blood vessel network length (length of blood vessel network (mm) per mm 2 in image). (data representative of 2 technical replicates, mean±SEM, p-value by two-way ANOVA).
    Human Umbilical Vein Endothelial Cells Huvecs, supplied by Angio-Proteomie, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gfp+huvec/GFP+Expressing+Human+Umbilical+Vein+Endothelial+Cells/pmc12777652-73-3-9
    Average 95 stars, based on 1 article reviews
    human umbilical vein endothelial cells huvecs - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    Image Search Results


    Acid-stimulated S1P, released by tumor cells, promotes tubulogenesis. (A,B) Quantifications and representative images of HUVEC-GFP cells treated with the CM of OS spheroids cultured in neutral or acidic conditions for 24 h (scale bar: 800 μm). The corresponding control (−) consisted of medium maintained at the same pH as that used for the spheroids. Mann–Whitney test (*p < 0.05 and **p < 0.01 versus neutral control; §§p < 0.01 vs. CM acid control; ###p < 0.005 vs. CM neutral control; n = 12). (C) S1P levels in CM of OS spheroids cultured for 96 h, at nuetral and acidic conditions, with or w/o FTY720 were determined by ELISA. Mann–Whitney test (*p < 0.05 vs. neutral control, #p < 0.05 vs. acid control). (D,E) Quantifications and representative images of HUVEC-GFP cells treated with the CM of OS spheroids, treated with FTY720, as indicated (scale bar: 800 μm). Mann–Whitney test (*p < 0.05 and ***p < 0.005 vs. neutral untreated control; #p < 0.05 vs. CM acid untreated control; n = 12). For all the experiments data are presented as mean ± SEM.

    Journal: Frontiers in Cell and Developmental Biology

    Article Title: Tumor-derived sphingosine-1-phosphate shapes angiogenesis in the acidic microenvironment of osteosarcoma via paracrine and autocrine signaling

    doi: 10.3389/fcell.2026.1831997

    Figure Lengend Snippet: Acid-stimulated S1P, released by tumor cells, promotes tubulogenesis. (A,B) Quantifications and representative images of HUVEC-GFP cells treated with the CM of OS spheroids cultured in neutral or acidic conditions for 24 h (scale bar: 800 μm). The corresponding control (−) consisted of medium maintained at the same pH as that used for the spheroids. Mann–Whitney test (*p < 0.05 and **p < 0.01 versus neutral control; §§p < 0.01 vs. CM acid control; ###p < 0.005 vs. CM neutral control; n = 12). (C) S1P levels in CM of OS spheroids cultured for 96 h, at nuetral and acidic conditions, with or w/o FTY720 were determined by ELISA. Mann–Whitney test (*p < 0.05 vs. neutral control, #p < 0.05 vs. acid control). (D,E) Quantifications and representative images of HUVEC-GFP cells treated with the CM of OS spheroids, treated with FTY720, as indicated (scale bar: 800 μm). Mann–Whitney test (*p < 0.05 and ***p < 0.005 vs. neutral untreated control; #p < 0.05 vs. CM acid untreated control; n = 12). For all the experiments data are presented as mean ± SEM.

    Article Snippet: Human umbilical vein endothelial cells (HUVEC-GFP) were obtained from PromoCell (Heidelberg, Germany) and cultured in Endothelial Cell Basal Medium (ECBM) (PromoCell) supplemented with Endothelial Cell Growth Medium Supplement Pack (PromoCell), 8% Fetal Bovine Serum (FBS) (Lonza, Basil, Switzerland) and 1% Penicillin/Streptomycin (EuroClone, Milan, Italy).

    Techniques: Cell Culture, Control, MANN-WHITNEY, Enzyme-linked Immunosorbent Assay

    S1P stimulates endothelial cells sprouting. (A) Representative images of endothelial vessel formation after 24 h in a microfluidic platform, shown as whole-channel microscopy (Xpress Pico, upper panels) and high-magnification confocal microscopy (Nikon, lower panels) images. Three-lane Mimetas® microchambers were used, with HUVEC-GFP cells seeded in the top channel, Matrigel® loaded into the central channel, and the bottom channel reserved for the angiogenic cocktail (VEGF with or w/o 250 nM S1P). Dashed boxes highlight regions shown in the confocal close-ups. Confocal images display maximum-intensity projections and 3D side-rendered views. Scale bars: 50 μm. (B) Sprouting quantification (Mann–Whitney test; *p < 0.05 vs. control, n = 10). (C) HUVEC cell proliferation in neutral or acidic medium in monolayer for the indicated time points. Cells were treated with or w/o S1P added in the medium. The total number of cells was assessed by staining of cell nuclei by Hoechst. Data presented as mean ± SEM. Mann–Whitney U test (*p < 0.05 vs. control, n = 8). (D,E) Quantification and representative images of node number and total tubule length in HUVEC-GFP cells, treated with different S1P concentrations (nM), 12 h after seeding. (Mann–Whitney test; *p < 0.05 versus control, n = 9).

    Journal: Frontiers in Cell and Developmental Biology

    Article Title: Tumor-derived sphingosine-1-phosphate shapes angiogenesis in the acidic microenvironment of osteosarcoma via paracrine and autocrine signaling

    doi: 10.3389/fcell.2026.1831997

    Figure Lengend Snippet: S1P stimulates endothelial cells sprouting. (A) Representative images of endothelial vessel formation after 24 h in a microfluidic platform, shown as whole-channel microscopy (Xpress Pico, upper panels) and high-magnification confocal microscopy (Nikon, lower panels) images. Three-lane Mimetas® microchambers were used, with HUVEC-GFP cells seeded in the top channel, Matrigel® loaded into the central channel, and the bottom channel reserved for the angiogenic cocktail (VEGF with or w/o 250 nM S1P). Dashed boxes highlight regions shown in the confocal close-ups. Confocal images display maximum-intensity projections and 3D side-rendered views. Scale bars: 50 μm. (B) Sprouting quantification (Mann–Whitney test; *p < 0.05 vs. control, n = 10). (C) HUVEC cell proliferation in neutral or acidic medium in monolayer for the indicated time points. Cells were treated with or w/o S1P added in the medium. The total number of cells was assessed by staining of cell nuclei by Hoechst. Data presented as mean ± SEM. Mann–Whitney U test (*p < 0.05 vs. control, n = 8). (D,E) Quantification and representative images of node number and total tubule length in HUVEC-GFP cells, treated with different S1P concentrations (nM), 12 h after seeding. (Mann–Whitney test; *p < 0.05 versus control, n = 9).

    Article Snippet: Human umbilical vein endothelial cells (HUVEC-GFP) were obtained from PromoCell (Heidelberg, Germany) and cultured in Endothelial Cell Basal Medium (ECBM) (PromoCell) supplemented with Endothelial Cell Growth Medium Supplement Pack (PromoCell), 8% Fetal Bovine Serum (FBS) (Lonza, Basil, Switzerland) and 1% Penicillin/Streptomycin (EuroClone, Milan, Italy).

    Techniques: Microscopy, Confocal Microscopy, MANN-WHITNEY, Control, Staining

    (A) Quantitative analysis of BrdU incorporation assay measuring endothelial cell proliferation. (B) Quantitative analysis of HUVEC migration and (C) representative images of HUVEC migration. Scale bar=100 µm. (D) Plot of HUVEC migration for 24 hours. (E) Representative images of GFP-HUVECs which were treated with 1 µg/mL EVs for 9 hours on GelTrex. Scale bar=500 µm. (F) Quantitative analysis of number of branches and (G) total tube length. Error bars in the graphs represent mean ± SD of EVs obtained from three or four independent donors. ****p < 0.0001, ***p <0.001, **p < 0.01, *p <0.05 (one-way ANOVA and Tukey multiple comparison).

    Journal: bioRxiv

    Article Title: Metabolic Reprogramming of Human Macrophages Drives the Formation of Hybrid M1/M2 Pro-Regenerative Extracellular Vesicles

    doi: 10.64898/2026.01.16.699890

    Figure Lengend Snippet: (A) Quantitative analysis of BrdU incorporation assay measuring endothelial cell proliferation. (B) Quantitative analysis of HUVEC migration and (C) representative images of HUVEC migration. Scale bar=100 µm. (D) Plot of HUVEC migration for 24 hours. (E) Representative images of GFP-HUVECs which were treated with 1 µg/mL EVs for 9 hours on GelTrex. Scale bar=500 µm. (F) Quantitative analysis of number of branches and (G) total tube length. Error bars in the graphs represent mean ± SD of EVs obtained from three or four independent donors. ****p < 0.0001, ***p <0.001, **p < 0.01, *p <0.05 (one-way ANOVA and Tukey multiple comparison).

    Article Snippet: Human umbilical vein endothelial cells (HUVECs) (Promocell, C-12203) and Green Fluorescent Protein (GFP) -HUVECs (Angio-proteomie, cAP-0001GFP) were cultured in endothelial cell basal medium (EBM) plus endothelial cell growth medium supplements (Promocell, C-22011) supplemented with 10% FBS (Gibco) and 1% Penicillin/Streptomycin (100 U/mL, Sigma, P4333) and incubated at 37°C in a humified 5% CO 2 atmosphere.

    Techniques: BrdU Incorporation Assay, Migration, Comparison

    (A) Quantitative analysis of BrdU incorporation assay measuring endothelial cell proliferation. (B) Quantitative analysis of HUVEC migration and (C) representative images of HUVEC migration. Scale bar= 100 µm. (D) Representative images of GFP-HUVECs which were treated with 1 µg/mL EVs for 9 hours on GelTrex. Scale bar=500 µm. ( E ) Quantitative analysis of number of branches and ( F ) total tube length. (G) Quantitative analysis of BrdU incorporation assay measuring MSC proliferation. (H) Quantitative analysis of MSC migration. (I) Alkaline phosphatase activity at day 7. (J) Alizarin Red staining at day 14 for mineralized matrix deposition (Scale bar=100 µm) and (K) quantification of calcium content. Error bars in the graphs represent mean ± SD of EVs obtained from three or four independent donors. ****p < 0.0001, ***p < 0.001, **p < 0.01, *p < 0.05 (one-way ANOVA and Tukey multiple comparison). Error bars in the graphs represent mean ± SD of EVs obtained from three or four independent donors.

    Journal: bioRxiv

    Article Title: Metabolic Reprogramming of Human Macrophages Drives the Formation of Hybrid M1/M2 Pro-Regenerative Extracellular Vesicles

    doi: 10.64898/2026.01.16.699890

    Figure Lengend Snippet: (A) Quantitative analysis of BrdU incorporation assay measuring endothelial cell proliferation. (B) Quantitative analysis of HUVEC migration and (C) representative images of HUVEC migration. Scale bar= 100 µm. (D) Representative images of GFP-HUVECs which were treated with 1 µg/mL EVs for 9 hours on GelTrex. Scale bar=500 µm. ( E ) Quantitative analysis of number of branches and ( F ) total tube length. (G) Quantitative analysis of BrdU incorporation assay measuring MSC proliferation. (H) Quantitative analysis of MSC migration. (I) Alkaline phosphatase activity at day 7. (J) Alizarin Red staining at day 14 for mineralized matrix deposition (Scale bar=100 µm) and (K) quantification of calcium content. Error bars in the graphs represent mean ± SD of EVs obtained from three or four independent donors. ****p < 0.0001, ***p < 0.001, **p < 0.01, *p < 0.05 (one-way ANOVA and Tukey multiple comparison). Error bars in the graphs represent mean ± SD of EVs obtained from three or four independent donors.

    Article Snippet: Human umbilical vein endothelial cells (HUVECs) (Promocell, C-12203) and Green Fluorescent Protein (GFP) -HUVECs (Angio-proteomie, cAP-0001GFP) were cultured in endothelial cell basal medium (EBM) plus endothelial cell growth medium supplements (Promocell, C-22011) supplemented with 10% FBS (Gibco) and 1% Penicillin/Streptomycin (100 U/mL, Sigma, P4333) and incubated at 37°C in a humified 5% CO 2 atmosphere.

    Techniques: BrdU Incorporation Assay, Migration, Activity Assay, Staining, Comparison

    A and B , Bioluminescence of HEK-293T VEGFR reporter cells treated with supernatant containing either anti-VEGF or anti-CD19 and recombinant VEGF (rVEGF) (Data from technical triplicates, points represent the mean, error bars represent SEM, p-value by two-way ANOVA) ( A ) or supernatant from confluent VEGF-producing 786O tumor cells (data from technical triplicates, lines represent the median, p-value by one-way ANOVA) ( B ). C, Schematic of in vitro angiogenesis assay to visualize blood vessel formation upon blocking VEGF. GFP + human umbilical vein endothelial cells (HUVECs) were cocultured with normal human dermal fibroblasts (NHDFs), suramin, rVEGF, and culture supernatant from CAR αCD19 or CAR αVEGF constructs and primitive blood vessel formation was imaged over time on the incucyte. D, Representative images of GFP + HUVECs with vessels labeled by the automated incucyte angiogenesis software package. E, HUVEC blood vessel network length (length of blood vessel network (mm) per mm 2 in image). (data representative of 2 technical replicates, mean±SEM, p-value by two-way ANOVA).

    Journal: Cancer immunology research

    Article Title: Secretion of a VEGF-blocking scFv enhances CAR T-cell potency

    doi: 10.1158/2326-6066.CIR-24-0876

    Figure Lengend Snippet: A and B , Bioluminescence of HEK-293T VEGFR reporter cells treated with supernatant containing either anti-VEGF or anti-CD19 and recombinant VEGF (rVEGF) (Data from technical triplicates, points represent the mean, error bars represent SEM, p-value by two-way ANOVA) ( A ) or supernatant from confluent VEGF-producing 786O tumor cells (data from technical triplicates, lines represent the median, p-value by one-way ANOVA) ( B ). C, Schematic of in vitro angiogenesis assay to visualize blood vessel formation upon blocking VEGF. GFP + human umbilical vein endothelial cells (HUVECs) were cocultured with normal human dermal fibroblasts (NHDFs), suramin, rVEGF, and culture supernatant from CAR αCD19 or CAR αVEGF constructs and primitive blood vessel formation was imaged over time on the incucyte. D, Representative images of GFP + HUVECs with vessels labeled by the automated incucyte angiogenesis software package. E, HUVEC blood vessel network length (length of blood vessel network (mm) per mm 2 in image). (data representative of 2 technical replicates, mean±SEM, p-value by two-way ANOVA).

    Article Snippet: After 3 days, Human Umbilical Vein Endothelial Cells (HUVECs) (Angio Proteomie, CAP0001GFP) were seeded onto the confluent layer of NHDFs at 5,000 cells/well and treatment conditions were added (recombinant VEGF at 4 ng/ml (R&D Systems 293-VE-010), suramin sodium salt at 0.25 mg/ml (Millipore Sigma, S2671–25MG), culture supernatant from confluent 70 αVEGF , 70 aCD19 , or untransduced Jurkat T cells diluted 1:4).

    Techniques: In Vitro, Recombinant, Angiogenesis Assay, Blocking Assay, Construct, Labeling, Software